Topical Antibiotics and the Hotlist Drug Boundary

Every few months someone writes in asking whether they can add a touch of an antibiotic active to a blemish serum, usually because a compounding pharmacist mentioned it or they read about it treating acne in a dermatology forum. The answer is almost always no, and the reason has less to do with any single ingredient being "banned" and more to do with what antibiotics do to a product's legal category the moment they show up on the label.

Why antibiotics don't sit in cosmetic territory

A cosmetic, by definition, cleanses, beautifies, or alters appearance without claiming to treat or prevent a disease. Antibiotics exist to kill or inhibit bacteria, which is a therapeutic function. The moment an ingredient's job is to treat an infection, you've crossed into drug regulation, and that's true whether you call the product a cosmetic on the label or not. Regulators look at function and claims together, not just the marketing category you picked.

This is why topical antibiotics like neomycin, bacitracin, or mupirocin never show up in a legitimate cosmetic ingredient deck. They aren't there because a hotlist entry specifically forbids the molecule (though several do appear on prohibited or restricted substance lists in various markets). They're excluded because their entire reason for existing is disease treatment, which makes any product containing them a drug, subject to drug review, clinical evidence requirements, and manufacturing standards that cosmetics don't carry.

The broader antimicrobial gray zone

It's not just prescription-grade antibiotics that trip this wire. A lot of makers get nervous about ingredients that sit closer to the line:

• Preservatives with antimicrobial action (phenoxyethanol, benzoic acid, sorbic acid) are fine. Their job is protecting the product from microbial growth, not treating a condition on skin.
• Tea tree oil and other "antibacterial" botanicals are usually fine as cosmetic ingredients, but the claim you put next to them matters enormously. "Cleansing" is cosmetic language. "Kills acne-causing bacteria" or "treats infection" starts to sound like a drug claim, even if the ingredient itself is unregulated.
• Antiperspirants and anti-dandruff products are treated as drugs in some markets specifically because they alter a body function or treat a condition, which is a good preview of how a regulator thinks about function over form.

The pattern across all of these: it's not always the molecule that decides the category, it's the combination of what the ingredient does and what you say it does.

What actually lands on hotlists

Health Canada's Cosmetic Ingredient Hotlist is the reference most Canadian sellers check first, and it lists both prohibited substances (can't be used at all) and restricted substances (allowed only under specific conditions, like a maximum concentration or a required warning). Antibiotic actives generally don't need a specific hotlist entry to be off-limits, because they fail the basic cosmetic definition before you even get to ingredient-level screening. But the hotlist is still where you'll find related antimicrobial agents that are restricted for other safety reasons, like certain quaternary ammonium compounds or specific preservative classes with concentration caps.

If you're formulating anything with an antimicrobial angle, a quick table helps keep the categories straight:

Ingredient type	Typical regulatory home	Common issue
Topical antibiotics (neomycin, mupirocin)	Drug	Therapeutic function, not cosmetic
Preservative antimicrobials (phenoxyethanol)	Cosmetic	Concentration limits, hotlist restrictions
Antiperspirant actives (aluminum salts)	Drug (in most markets)	Alters a body function
Antibacterial claims on soap	Depends on wording	"Kills germs" claims invite drug scrutiny

What to do if you're tempted

If a formula genuinely needs antimicrobial performance beyond preservation, the honest path is to ask whether you're actually building a drug product and need to go through that regulatory door instead of trying to squeeze a therapeutic ingredient into a cosmetic filing. That's a much bigger undertaking, with different evidence and labeling requirements, and it's worth having that conversation with a regulatory consultant before you formulate rather than after.

For everything that does stay on the cosmetic side, the practical work is making sure every active in your deck is screened against the current hotlist and that your claims language never wanders into "treats" or "kills bacteria" territory. Cosmetic Comply runs that ingredient-by-ingredient screening automatically against Canada's hotlist, flags anything that looks restricted or prohibited with a confidence score, and has a real reviewer check the result before anything gets filed. It won't tell you whether your product is secretly a drug, but it will stop a hotlist violation from slipping through on the cosmetic side of the line.